$ACAN
AmeriCann, Inc.

2023 Q1 Form 10-Q Financial Statement

#000143774923003222 Filed on February 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $748.4K $734.8K $651.0K
YoY Change 12.14% 12.88% 139.69%
Cost Of Revenue $0.00 $13.62K $11.45K
YoY Change -100.0% 18.91% 52.67%
Gross Profit $748.4K $721.2K $639.5K
YoY Change 13.94% 12.77% 142.15%
Gross Profit Margin 100.0% 98.15% 98.24%
Selling, General & Admin $479.3K $513.2K $1.008M
YoY Change 1.59% -49.09% 75.58%
% of Gross Profit 64.04% 71.17% 157.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $113.3K $112.5K $112.5K
YoY Change 0.74% 0.0% -0.13%
% of Gross Profit 15.14% 15.6% 17.59%
Operating Expenses $479.2K $513.2K $1.008M
YoY Change 1.59% -49.09% 77.9%
Operating Profit $269.2K $207.9K -$368.6K
YoY Change 45.4% -156.4% 21.83%
Interest Expense -$182.5K -$185.2K -$164.4K
YoY Change 13.46% 12.63% -17.67%
% of Operating Profit -67.82% -89.06%
Other Income/Expense, Net -$182.5K -$185.2K -$164.4K
YoY Change 13.46% 12.63% -17.67%
Pretax Income $86.62K $22.75K -$533.0K
YoY Change 257.34% -104.27% 6.12%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $86.62K $22.75K -$533.0K
YoY Change 257.35% -104.27% 6.12%
Net Earnings / Revenue 11.57% 3.1% -81.88%
Basic Earnings Per Share $0.00 $0.00 -$0.02
Diluted Earnings Per Share $0.00 $0.00 -$22.01K
COMMON SHARES
Basic Shares Outstanding 24.39M 24.39M 24.22M
Diluted Shares Outstanding 24.39M 24.39M 24.22M

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.253M $1.273M $741.0K
YoY Change 53.75% 71.85% 65.29%
Cash & Equivalents $1.253M $1.273M $740.9K
Short-Term Investments
Other Short-Term Assets $43.30K $13.30K $10.21K
YoY Change 0.0% 30.26% -22.0%
Inventory
Prepaid Expenses
Receivables $21.47K $235.9K
Other Receivables $267.7K $43.46K
Total Short-Term Assets $1.585M $1.561M $1.030M
YoY Change 38.6% 51.46% 60.79%
LONG-TERM ASSETS
Property, Plant & Equipment $13.70M $13.64M $13.96M
YoY Change -1.42% -2.31% 88.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.70M $13.64M $13.99M
YoY Change -1.56% -2.53% -2.61%
TOTAL ASSETS
Total Short-Term Assets $1.585M $1.561M $1.030M
Total Long-Term Assets $13.70M $13.64M $13.99M
Total Assets $15.29M $15.20M $15.02M
YoY Change 1.49% 1.17% 0.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $85.19K $129.8K $67.50K
YoY Change 3.26% 92.36% -20.59%
Accrued Expenses $53.78K $58.00K $82.44K
YoY Change -11.0% -29.65% -7.61%
Deferred Revenue
YoY Change
Short-Term Debt $4.435M $4.386M $150.0K
YoY Change 2856.71% 2824.23% -50.17%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.583M $4.581M $519.2K
YoY Change 799.66% 782.2% -36.52%
LONG-TERM LIABILITIES
Long-Term Debt $581.7K $581.7K $4.838M
YoY Change -88.04% -87.98% 5.67%
Other Long-Term Liabilities $4.211M $4.214M $4.225M
YoY Change -0.28% -0.27% -0.43%
Total Long-Term Liabilities $4.792M $4.795M $9.063M
YoY Change -47.26% -47.09% 2.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.583M $4.581M $519.2K
Total Long-Term Liabilities $4.792M $4.795M $9.063M
Total Liabilities $9.375M $9.376M $9.582M
YoY Change -2.3% -2.16% -0.59%
SHAREHOLDERS EQUITY
Retained Earnings -$19.65M -$19.74M -$20.12M
YoY Change -2.21% -1.9% 4.65%
Common Stock $2.439K $2.439K $2.439K
YoY Change 0.0% 0.0% 2.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.911M $5.825M $5.442M
YoY Change
Total Liabilities & Shareholders Equity $15.29M $15.20M $15.02M
YoY Change 1.49% 1.17% 0.09%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income $86.62K $22.75K -$533.0K
YoY Change 257.35% -104.27% 6.12%
Depreciation, Depletion And Amortization $113.3K $112.5K $112.5K
YoY Change 0.74% 0.0% -0.13%
Cash From Operating Activities $161.5K $111.3K $125.3K
YoY Change 24.42% -11.22% -151.7%
INVESTING ACTIVITIES
Capital Expenditures $192.0K $40.68K -$90.49K
YoY Change -391.0% -144.96%
Acquisitions
YoY Change
Other Investing Activities $10.12K $11.60K $9.710K
YoY Change -0.2% 19.46% 19.58%
Cash From Investing Activities -$181.9K -$29.08K -$80.79K
YoY Change 225.77% -64.0% -1095.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -$150.0K $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 161.5K $111.3K $125.3K
Cash From Investing Activities -181.9K -$29.08K -$80.79K
Cash From Financing Activities 0.000 -$150.0K $0.00
Net Change In Cash -20.45K -$67.81K $44.54K
YoY Change -127.66% -252.23% -83.24%
FREE CASH FLOW
Cash From Operating Activities $161.5K $111.3K $125.3K
Capital Expenditures $192.0K $40.68K -$90.49K
Free Cash Flow -$30.57K $70.59K $215.8K
YoY Change -115.62% -67.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001508348
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
31581 usd
CY2022Q3 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
43185 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
82500 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
581646 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
581646 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2022Q4 acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
0 usd
CY2021Q4 acan Operating Lease Lease Income Related Party
OperatingLeaseLeaseIncomeRelatedParty
407264 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
721151 usd
CY2022Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1418 usd
CY2021Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
12967 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
120513 usd
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
125059 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
391306 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
870088 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
513237 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
1008114 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
207914 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-368619 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1663 usd
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
3561 usd
CY2022Q4 us-gaap Interest Expense Other
InterestExpenseOther
186832 usd
CY2021Q4 us-gaap Interest Expense Other
InterestExpenseOther
154775 usd
CY2022Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
-0 usd
CY2021Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
13195 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-185169 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164409 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-533028 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24219703
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
5510410 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000 usd
CY2021Q4 acan Warrants Extension
WarrantsExtension
374946 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5442328 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5802112 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5824857 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-533028 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112481 usd
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112481 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17228 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17021 usd
CY2022Q4 acan Share Based Compensation And Fair Value Adjustment Of Warrants Expense
ShareBasedCompensationAndFairValueAdjustmentOfWarrantsExpense
0 usd
CY2021Q4 acan Share Based Compensation And Fair Value Adjustment Of Warrants Expense
ShareBasedCompensationAndFairValueAdjustmentOfWarrantsExpense
374946 usd
CY2022Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2021Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
90000 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
48706 usd
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25976 usd
CY2022Q4 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
-8912 usd
CY2021Q4 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
-0 usd
CY2022Q4 acan Increase Decrease In Tenant Receivable Related Party
IncreaseDecreaseInTenantReceivableRelatedParty
-0 usd
CY2021Q4 acan Increase Decrease In Tenant Receivable Related Party
IncreaseDecreaseInTenantReceivableRelatedParty
-22985 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-59433 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12735 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63328 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25433 usd
CY2022Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2739 usd
CY2021Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2531 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-82500 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-30000 usd
CY2022Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-7476 usd
CY2021Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4414 usd
CY2022Q4 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
0 usd
CY2021Q4 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
13194 usd
CY2022Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2192 usd
CY2021Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-8297 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111270 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
125329 usd
CY2022Q4 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
40684 usd
CY2021Q4 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
90492 usd
CY2022Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
11604 usd
CY2021Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
9706 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29080 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80786 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
CY2021Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-67810 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44543 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1351094 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
706369 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1283284 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
750912 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
145602 usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
124386 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19735944 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19758689 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1273317 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1341127 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1283284 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1351094 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427 usd
CY2021Q4 us-gaap Depreciation
Depreciation
112481 usd
CY2022Q4 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.180 pure
CY2022Q3 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.180 pure
CY2022Q4 acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
4422 usd
CY2022 acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
4422 usd
CY2022Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
31581 usd
CY2022Q3 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
43185 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-533028 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24219703
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24219703
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957 usd
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6760857 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11507 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4213633 usd
CY2022Q4 acan Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
98354 usd
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P43Y9M
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079 pure
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
256123 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500 usd
CY2022Q4 acan Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
13318505 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14940628 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10715488 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4225140 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11507 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4213633 usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
120344 usd
CY2021Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
114218 usd
CY2021Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
195651
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4026650
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.21
CY2022 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P0Y9M18D
CY2022Q4 acan Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
-1815000
CY2022Q4 acan Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
1.50
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2211650
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.32
CY2022Q4 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y1M6D
CY2022Q4 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2211650
CY2022Q4 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.32
CY2022Q4 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P2Y1M6D

Files In Submission

Name View Source Status
0001437749-23-003222-index-headers.html Edgar Link pending
0001437749-23-003222-index.html Edgar Link pending
0001437749-23-003222.txt Edgar Link pending
0001437749-23-003222-xbrl.zip Edgar Link pending
acan-20221231.xsd Edgar Link pending
acan20221231_10q.htm Edgar Link pending
ex_471165.htm Edgar Link pending
ex_471166.htm Edgar Link pending
ex_471167.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
acan-20221231_cal.xml Edgar Link unprocessable
acan-20221231_lab.xml Edgar Link unprocessable
acan-20221231_def.xml Edgar Link unprocessable
acan-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acan20221231_10q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending